288 related articles for article (PubMed ID: 37331971)
1. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
[TBL] [Abstract][Full Text] [Related]
2. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
[TBL] [Abstract][Full Text] [Related]
3. Impaired very long-chain acyl-CoA β-oxidation in human X-linked adrenoleukodystrophy fibroblasts is a direct consequence of ABCD1 transporter dysfunction.
Wiesinger C; Kunze M; Regelsberger G; Forss-Petter S; Berger J
J Biol Chem; 2013 Jun; 288(26):19269-79. PubMed ID: 23671276
[TBL] [Abstract][Full Text] [Related]
4. Caffeic acid phenethyl ester induces adrenoleukodystrophy (Abcd2) gene in human X-ALD fibroblasts and inhibits the proinflammatory response in Abcd1/2 silenced mouse primary astrocytes.
Singh J; Khan M; Singh I
Biochim Biophys Acta; 2013 Apr; 1831(4):747-58. PubMed ID: 23318275
[TBL] [Abstract][Full Text] [Related]
5. HDAC inhibitor SAHA normalizes the levels of VLCFAs in human skin fibroblasts from X-ALD patients and downregulates the expression of proinflammatory cytokines in Abcd1/2-silenced mouse astrocytes.
Singh J; Khan M; Singh I
J Lipid Res; 2011 Nov; 52(11):2056-69. PubMed ID: 21891797
[TBL] [Abstract][Full Text] [Related]
6. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
[TBL] [Abstract][Full Text] [Related]
7. ABCD1 Transporter Deficiency Results in Altered Cholesterol Homeostasis.
Buda A; Forss-Petter S; Hua R; Jaspers Y; Lassnig M; Waidhofer-Söllner P; Kemp S; Kim P; Weinhofer I; Berger J
Biomolecules; 2023 Aug; 13(9):. PubMed ID: 37759733
[TBL] [Abstract][Full Text] [Related]
8. ABCD1 deletion-induced mitochondrial dysfunction is corrected by SAHA: implication for adrenoleukodystrophy.
Baarine M; Beeson C; Singh A; Singh I
J Neurochem; 2015 May; 133(3):380-96. PubMed ID: 25393703
[TBL] [Abstract][Full Text] [Related]
9. Impaired mitochondrial oxidative phosphorylation in the peroxisomal disease X-linked adrenoleukodystrophy.
López-Erauskin J; Galino J; Ruiz M; Cuezva JM; Fabregat I; Cacabelos D; Boada J; Martínez J; Ferrer I; Pamplona R; Villarroya F; Portero-Otín M; Fourcade S; Pujol A
Hum Mol Genet; 2013 Aug; 22(16):3296-305. PubMed ID: 23604518
[TBL] [Abstract][Full Text] [Related]
10. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
[TBL] [Abstract][Full Text] [Related]
11. ABCD1 and X-linked adrenoleukodystrophy: A disease with a markedly variable phenotype showing conserved neurobiology in animal models.
Manor J; Chung H; Bhagwat PK; Wangler MF
J Neurosci Res; 2021 Dec; 99(12):3170-3181. PubMed ID: 34716609
[TBL] [Abstract][Full Text] [Related]
12. X-linked adrenoleukodystrophy: very long-chain fatty acid metabolism is severely impaired in monocytes but not in lymphocytes.
Weber FD; Wiesinger C; Forss-Petter S; Regelsberger G; Einwich A; Weber WH; Köhler W; Stockinger H; Berger J
Hum Mol Genet; 2014 May; 23(10):2542-50. PubMed ID: 24363066
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of X-linked adrenoleukodystrophy.
Berger J; Forss-Petter S; Eichler FS
Biochimie; 2014 Mar; 98(100):135-42. PubMed ID: 24316281
[TBL] [Abstract][Full Text] [Related]
14. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.
Ma CY; Li C; Zhou X; Zhang Z; Jiang H; Liu H; Chen HJ; Tse HF; Liao C; Lian Q
Biomed Pharmacother; 2021 Nov; 143():112214. PubMed ID: 34560537
[TBL] [Abstract][Full Text] [Related]
15. Epigenomic signature of adrenoleukodystrophy predicts compromised oligodendrocyte differentiation.
Schlüter A; Sandoval J; Fourcade S; Díaz-Lagares A; Ruiz M; Casaccia P; Esteller M; Pujol A
Brain Pathol; 2018 Nov; 28(6):902-919. PubMed ID: 29476661
[TBL] [Abstract][Full Text] [Related]
16. 25-hydroxycholesterol contributes to cerebral inflammation of X-linked adrenoleukodystrophy through activation of the NLRP3 inflammasome.
Jang J; Park S; Jin Hur H; Cho HJ; Hwang I; Pyo Kang Y; Im I; Lee H; Lee E; Yang W; Kang HC; Won Kwon S; Yu JW; Kim DW
Nat Commun; 2016 Oct; 7():13129. PubMed ID: 27779191
[TBL] [Abstract][Full Text] [Related]
17. Evidence of oxidative stress in very long chain fatty acid--treated oligodendrocytes and potentialization of ROS production using RNA interference-directed knockdown of ABCD1 and ACOX1 peroxisomal proteins.
Baarine M; Andréoletti P; Athias A; Nury T; Zarrouk A; Ragot K; Vejux A; Riedinger JM; Kattan Z; Bessede G; Trompier D; Savary S; Cherkaoui-Malki M; Lizard G
Neuroscience; 2012 Jun; 213():1-18. PubMed ID: 22521832
[TBL] [Abstract][Full Text] [Related]
18. Impaired plasticity of macrophages in X-linked adrenoleukodystrophy.
Weinhofer I; Zierfuss B; Hametner S; Wagner M; Popitsch N; Machacek C; Bartolini B; Zlabinger G; Ohradanova-Repic A; Stockinger H; Köhler W; Höftberger R; Regelsberger G; Forss-Petter S; Lassmann H; Berger J
Brain; 2018 Aug; 141(8):2329-2342. PubMed ID: 29860501
[TBL] [Abstract][Full Text] [Related]
19. A zebrafish model of X-linked adrenoleukodystrophy recapitulates key disease features and demonstrates a developmental requirement for abcd1 in oligodendrocyte patterning and myelination.
Strachan LR; Stevenson TJ; Freshner B; Keefe MD; Miranda Bowles D; Bonkowsky JL
Hum Mol Genet; 2017 Sep; 26(18):3600-3614. PubMed ID: 28911205
[TBL] [Abstract][Full Text] [Related]
20. Neural Stem Cells of the Subventricular Zone Contribute to Neuroprotection of the Corpus Callosum after Cuprizone-Induced Demyelination.
Butti E; Bacigaluppi M; Chaabane L; Ruffini F; Brambilla E; Berera G; Montonati C; Quattrini A; Martino G
J Neurosci; 2019 Jul; 39(28):5481-5492. PubMed ID: 31138656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
